James Adox
SlowingNamed in filings at Venture Investors HealthOn the current fund
- Board seats filed
- 9
Named in filings at Venture Investors HealthOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Dvant Pharma | Biotech & pharma | September 2026 | None on file |
| EarliTec Diagnostics | Medical devices | March 2024 | None on file |
| ViaLase | Medical devices | March 2019 | Arboretum Ventures, U.S Venture Partners, Versant Venture Capital |
| SkySpecs | Climate & energy | November 2015 | None on file |
| Reshape Medical | Medical devices | June 2014 | New Leaf, SV Life Sciences, U.S Venture Partners |
| TISSUE REGENERATION SYSTEMS | Medical devices | April 2014 | None on file |
| UpTo | Enterprise software | January 2014 | None on file |
| NETSOCKET | Enterprise software | September 2013 | None on file |
| HistoSonics | Medical devices | December 2009 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name James Adox on the board, based on 9 filed seats with a verified or cited source.